APA

Angelergues A., Efstathiou E., Gyftaki R., Wysocki P. J., Lainez N., Gonzalez I., Castellano D. E., Ozguroglu M., Carbonero I. G., Flechon A., Borrega P., Guillot A., Balea B. C., Le Moulec S., Esteban E., Munarriz J., Rubio G., Birtle A. J., Delanoy N., Bellmunt J. & Oudard S. (20190205). Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents. : Clinical genitourinary cancer.

Chicago

Angelergues Antoine, Efstathiou Eleni, Gyftaki Revekka, Wysocki Piotr Jan, Lainez Nuria, Gonzalez Iria, Castellano Daniel E, Ozguroglu Mustafa, Carbonero Iciar Garcia, Flechon Aude, Borrega Pablo, Guillot Aline, Balea Begona Campos, Le Moulec Sylvestre, Esteban Emilio, Munarriz Javier, Rubio Gustavo, Birtle Alison J, Delanoy Nicolas, Bellmunt Joaquim and Oudard Stéphane. 20190205. Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents. : Clinical genitourinary cancer.

Harvard

Angelergues A., Efstathiou E., Gyftaki R., Wysocki P. J., Lainez N., Gonzalez I., Castellano D. E., Ozguroglu M., Carbonero I. G., Flechon A., Borrega P., Guillot A., Balea B. C., Le Moulec S., Esteban E., Munarriz J., Rubio G., Birtle A. J., Delanoy N., Bellmunt J. and Oudard S. (20190205). Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents. : Clinical genitourinary cancer.

MLA

Angelergues Antoine, Efstathiou Eleni, Gyftaki Revekka, Wysocki Piotr Jan, Lainez Nuria, Gonzalez Iria, Castellano Daniel E, Ozguroglu Mustafa, Carbonero Iciar Garcia, Flechon Aude, Borrega Pablo, Guillot Aline, Balea Begona Campos, Le Moulec Sylvestre, Esteban Emilio, Munarriz Javier, Rubio Gustavo, Birtle Alison J, Delanoy Nicolas, Bellmunt Joaquim and Oudard Stéphane. Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents. : Clinical genitourinary cancer. 20190205.